As Heidi Overton’s HELP Committee Vote Looms Tomorrow, Reproductive Freedom for All Calls on Senators to Reject Her Nomination as FDA Commissioner - Reproductive Freedom for All®

Formerly NARAL Pro-Choice America

Reproductive Freedom for All®

Donate

Menu

Press Release

As Heidi Overton’s HELP Committee Vote Looms Tomorrow, Reproductive Freedom for All Calls on Senators to Reject Her Nomination as FDA Commissioner

Reproductive Freedom for All

For Immediate Release: Tuesday, November 17, 2026
Contact: [email protected]

As Heidi Overton’s HELP Committee Vote Looms Tomorrow, Reproductive Freedom for All Calls on Senators to Reject Her Nomination as FDA Commissioner

Washington, DC — Tomorrow, the Senate Health, Education, Labor, and Pensions (HELP) Committee will vote on anti-abortion extremist Heidi Overton’s nomination to lead the Food and Drug Administration (FDA). Reproductive Freedom for All is calling on Senators to reject Overton, an extremist who has called abortion “corrosive” and would helm the FDA’s mifepristone review in the final months before the agency’s March deadline to release its results. Republicans’ attempt to jam through Overton’s confirmation during the lame duck session directly opposes the mandate voters sent in November for their freedoms and rights to be protected.

Reproductive Freedom for All President and CEO Mini Timmaraju released the following statement:

“Earlier this month, voters delivered a decisive rejection of the anti-abortion agenda Heidi Overton would bring to the FDA. Senate Republicans are shamelessly trying to shoehorn her nomination through the final weeks of their  majority to undermine the future of abortion medication—Senators must reject her bid.”

As FDA Commissioner, Overton would oversee the regulation of birth control, emergency contraception, and medication abortion. She would also oversee the FDA’s sham review of mifepristone, which the agency has said will conclude by March 2027. At her September confirmation hearing, she repeatedly refused to say whether she believes mifepristone is safe, and she called the agency’s politically motivated review of the medication “very important.” Mifepristone has been FDA-approved for 26 years, and more than 100 peer-reviewed studies confirm its safety and efficacy.

Overton also held various leadership roles at the America First Policy Institute—a conservative think tank that helps push an anti-reproductive freedom and anti-LGBTQ+ agenda. In this capacity, she celebrated the Supreme Court’s Dobbs decision as a “huge victory” and characterized abortion as “corrosive.” She also supports defunding Planned Parenthood and diverting taxpayer funding to anti-abortion centers.

The FDA is tasked with protecting and promoting public health, but Overton’s nomination could mark a critical turning point for the agency’s priorities as Trump continues to install high-level political appointees who will do the bidding of anti-abortion groups instead of following the science. Heidi Overton has built her career on attacking reproductive freedom, and her confirmation would pose an immediate threat to reproductive healthcare, including mifepristone access.

###

For over 55 years, Reproductive Freedom for All (formerly NARAL Pro-Choice America) has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. Reproductive Freedom for All is powered by its more than 4.5 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.